OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System
Andrew D. Krystal, Ruth M. Benca, Thomas S. Kilduff
The Journal of Clinical Psychiatry (2013) Vol. 74, Iss. suppl 1, pp. 3-20
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Review of Safety and Efficacy of Sleep Medicines in Older Adults
Jennifer Schroeck, James M. Ford, Erin Conway, et al.
Clinical Therapeutics (2016) Vol. 38, Iss. 11, pp. 2340-2372
Open Access | Times Cited: 308

Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis
Taro Kishi, Ikuo Nomura, Yuki Matsuda, et al.
Journal of Psychiatric Research (2020) Vol. 128, pp. 68-74
Closed Access | Times Cited: 79

Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 25

Circadian rhythms have broad implications for understanding brain and behavior
Rae Silver, Lance J. Kriegsfeld
European Journal of Neuroscience (2014) Vol. 39, Iss. 11, pp. 1866-1880
Open Access | Times Cited: 77

Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Taro Kishi, Shinji Matsunaga, Nakao Iwata
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0136910-e0136910
Open Access | Times Cited: 72

Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis
Yingjie Dong, Ning-Hua Jiang, Lianghui Zhan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112141-112141
Open Access | Times Cited: 55

Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18

Acupuncture for primary insomnia: Effectiveness, safety, mechanisms and recommendations for clinical practice
Fei-Yi Zhao, Sarah J. Spencer, Gerard A. Kennedy, et al.
Sleep Medicine Reviews (2023) Vol. 74, pp. 101892-101892
Closed Access | Times Cited: 16

Pharmacological Treatment of Insomnia
Paula K. Schweitzer, Stephen D. Feren
Springer eBooks (2016), pp. 97-132
Closed Access | Times Cited: 58

Increased plasma orexin-A levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms
Shi Tang, Weiwei Huang, Shanshan Lu, et al.
Peptides (2016) Vol. 88, pp. 55-61
Closed Access | Times Cited: 53

Circadian aspects in nonpharmacologic and pharmacologic treatment of insomnia
Laura Palagini, Pierre A. Geoffroy, Raffaele Manni, et al.
Handbook of clinical neurology (2025), pp. 161-179
Closed Access

Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
Sydney M. Ragsdale, John M. Radovich, Isabel I. Coiduras, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
Sarah L. Anderson, Jessica Norman
Nature and Science of Sleep (2016) Vol. Volume 8, pp. 239-247
Open Access | Times Cited: 44

Hypnotic Effects of Lactobacillus fermentum PS150TM on Pentobarbital-Induced Sleep in Mice
Alexander Y. Lin, Ching-Ting Shih, Chin-Lin Huang, et al.
Nutrients (2019) Vol. 11, Iss. 10, pp. 2409-2409
Open Access | Times Cited: 40

Publication analysis on insomnia: how much has been done in the past two decades?
Yan Ma, Ming Dong, Carol Mita, et al.
Sleep Medicine (2015) Vol. 16, Iss. 7, pp. 820-826
Closed Access | Times Cited: 36

Circadian rhythm and sleep-wake systems share the dynamic extracellular synaptic milieu
Joanna M. Cooper, Kathryn A. Halter, Rebecca A. Prosser
Neurobiology of Sleep and Circadian Rhythms (2018) Vol. 5, pp. 15-36
Open Access | Times Cited: 33

The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29

Sleep, Cognition, and Yoga
Usha Panjwani, Sharmila Dudani, Meetu Wadhwa
International Journal of Yoga (2021) Vol. 14, Iss. 2, pp. 100-108
Open Access | Times Cited: 26

Translational approaches to influence sleep and arousal
Ritchie E. Brown, Tristan J. Spratt, Gary B. Kaplan
Brain Research Bulletin (2022) Vol. 185, pp. 140-161
Open Access | Times Cited: 17

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Alessandra Matzeu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9

Hypocretinergic and cholinergic contributions to sleep-wake disturbances in a mouse model of traumatic brain injury
Hannah E. Thomasy, Heidi Y Febinger, Kristyn M. Ringgold, et al.
Neurobiology of Sleep and Circadian Rhythms (2016) Vol. 2, pp. 71-84
Open Access | Times Cited: 29

Page 1 - Next Page

Scroll to top